Navigation Links
Berkery Noyes Releases First Half 2011 M&A Report for the Pharma and Healthcare Information and Technology Industry
Date:7/20/2011

NEW YORK, July 20, 2011 /PRNewswire/ -- Berkery Noyes, the leading independent investment bank specializing in the information content and technology industries, today released its Half Year Mergers and Acquisitions Trends Report for the Pharma and Healthcare Information and Technology Industry.

The report analyzes merger and acquisition activity in the Pharma and Healthcare Information and Technology market over the first half of 2011 and compares it with activity in the four previous sixth-month periods. This market includes information and technology companies servicing pharma, healthcare payor and healthcare provider spaces.

Berkery Noyes data shows that while deal volume increased by seven percent to 143 transactions announced this half year, total aggregate deal value fell 28 percent to $3.4 billion from $4.8 billion in 2nd Half 2010.  Despite this, both median deal value and median EBITDA multiples rose over the same time period.

"The data confirms what we are seeing in our deal flow," said Tom O'Connor, managing director at Berkery Noyes. "Strategic buyers, including those with private equity backing, are looking to acquire smaller, fast growing companies with unique solutions in their current or related markets. We expected M&A activity in Pharma and Healthcare Information and Technology sectors to be robust for the next 18 to 24 months."

Reed Elsevier and LLR Partners both announced three transactions this half year, tying as the most acquisitive companies in the Pharma and Healthcare space.  Reed Elsevier purchased an e-clinical reference solution and two medical media companies, while LLR Partners focused their three purchases on medical record management.  

For the full two-and-a-half period covered by the report, UnitedHealth Group was the most active acquirer covered in this report, making nine transactions: A-Life Medical, Inc., Axolotl Corporation, Executive Health Resources, Inc., Picis, Inc., ChinaGate, QualityMetric, Inc., Scriptswitch Limited, CareMedic Systems, Inc. and AIM Healthcare Services, Inc.

Unique among investment banking firms, Berkery Noyes combines independent strategic research and industry intelligence with senior information technology banking expertise. Long having been an innovator in database and research technology in M&A, Berkery Noyes has committed itself to providing more expansive and more current information on the acquisition activity in their respective sectors.

A copy of the First Half 2011 Pharma and Healthcare Information and Technology Industry M&A Report is available at the Berkery Noyes website.

About Berkery Noyes

Berkery Noyes is an independent investment banking advisory firm servicing the information industry. Focused on middle-market corporations and financial sponsors, Berkery Noyes is committed to delivering a comprehensive array of industry-leading advisory services. Since its founding by Joseph W. Berkery in 1983, the firm has worked with corporate clients to grow through acquisition, divest non-core assets, and maximize shareholder returns through strategic transactions and restructurings. For private owners, Berkery Noyes helps create liquidity and execute timely exit strategies that achieve the personal and professional objectives. For more information, visit www.berkerynoyes.com.


'/>"/>
SOURCE Berkery Noyes
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
2. Berkery Noyes Releases 2009 Pharma and Healthcare Information Merger & Acquisition Trends
3. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
4. CEL-SCI Corporation Releases Letter to Shareholders
5. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
6. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
7. Immunosyn Corporation Releases SF-1019 Study Results
8. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
9. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
10. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
11. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition of the ... ... energy-based aesthetic devices market to grow at a CAGR of 8.12% ... Aesthetic Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:3/29/2017)... , March 29, 2017  BioSpecifics Technologies ... and continues to develop collagenase based-therapies with a ... (CCH) marketed as XIAFLEX ®  in the U.S. ... will present a corporate overview at the upcoming ... Wednesday, April 5, 2017 at 8:00 a.m. ET ...
(Date:3/29/2017)... , Mar. 29, 2017 Research ... Navigation Systems Market 2014 - 2025" report to their ... ... reach USD 303.7 million by 2025. Increasing geriatric population prone ... demand for orthopedic navigation systems over the forecast period. Osteoarthritis ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... ARI Network Services, Inc. (NASDAQ: ARIS) ... eligible dealer websites for its network of more than 650 U.S.-based dealers. Rhino, a ... equipment including rotary and flail mowers and cutters, rear blades, post hole diggers, pasture ...
(Date:3/29/2017)... FL (PRWEB) , ... March 30, 2017 , ... Grass pollen is the main cause ... allergic to the stuff. The season for grass pollen runs from May to July each ... a hay fever victim to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an ...
(Date:3/29/2017)... ... ... Brand EXOUS Bodygear announced today a special sale price for the EX-701 Knee ... the price will be only $19.97. The EXOUS Bodygear 65cm exercise ball ... $19.97). , The special promotional prices are to help individuals get their products at ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based on research from ... employers face in trying to balance both short-term and long-term benefits demands. ... to the growing complexity, companies are finding that the short-term strategies used to ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... and other outpatient facilities, and who are the most active developers? , ... Revista and Healthcare Real Estate Insights (HREI) found that outpatient medical real estate ...
Breaking Medicine News(10 mins):